Depot-Specific Biology of Adipose Tissues: Links to Fat Distribution and Metabolic Risk

Adipose Tissue in Health and Disease

Volumn , Issue , 2010, Pages 283-306

  Lee, Mi jeong ^a   Fried, Susan K ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Adipocyte; Adipose tissue; Fat distribution; Lipolysis; Metabolic risk; Triglyceride

Indexed keywords

EID: 84885550848     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527629527.ch15     Document Type: Chapter

References (133)

1. St-Pierre, J., Lemieux, I., Perron, P., Brisson, D., Santure, M., Vohl, M.C., Despres, J.P., and Gaudet, D. (2007) Relation of the "hypertriglyceridemic waist" phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am. J. Cardiol., 99, 369-373.
2. Vega, G.L., Asam-Huet, B., Peshock, R., Willett, D., Shah, B., and Grundy, S.M. (2006) Influence of body fat content and distribution on variation in metabolic risk. J. Clin. Endocrinol. Metab., 91, 4459-4466.
3. Snijder, M.B., Visser, M., Dekker, J.M., Goodpaster, B.H., Harris, T.B., Kritchevsky, S.B., De, R.N., Kanaya, A.M., Newman, A.B., Tylavsky, F.A., and Seidell, J.C. (2005) Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study. Diabetologia, 48, 301-308.
4. Despres, J.P. and Lemieux, I. (2006) Abdominal obesity and metabolic syndrome. Nature, 444, 881-887.
5. Greenberg, A.S. and Obin, M.S. (2006) Obesity and the role of adipose tissue in inflammation and metabolism. Am. J. Clin. Nutr., 83, 461S-465.
6. Cinti, S. (2005) The adipose organ. Prostaglandins Leukot. Essent. Fatty Acids, 73, 9-15.
7. Fried, S.K. and Ross, R.J.R. (2005) The biology of visceral adipose tissue, in Handbook of Obesity: Clinical Applications, 2nd edn (eds G.A. Bray and C. Bouchard), Marcel Dekker, New York.
8. Trujillo, M.E. and Scherer, P.E. (2006) Adipose tissue-derived factors: impact on health and disease. Endocr. Rev., 27, 762-778.
9. Smith, S.R., Lovejoy, J.C., Greenway, F., Ryan, D., deJonge, L., de la, B.J.,Volafova, J., and Bray, G.A. (2001) Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism, 50, 425-435.
10. Litbarg, N.O., Gudehithlu, K.P., Sethupathi, P., Arruda, J.A., Dunea, G., and Singh, A.K. (2007) Activated omentum becomes rich in factors that promote healing and tissue regeneration. Cell Tissue Res., 328, 487-497.
11. Sacks, H.S. and Fain, J.N. (2007) Human epicardial adipose tissue: a review. Am. Heart J., 153, 907-917.
12. Cinti, S. (2001) The adipose organ: morphological perspectives of adipose tissues. Proc. Nutr. Soc., 60, 319-328.
13. Crandall, D.L. and DiGirolamo, M. (1990) Hemodynamic and metabolic correlates in adipose tissue: pathophysiologic considerations. FASEB J., 4, 141-147.
14. Bartness, T.J. and Song, C.K. (2007) Thematic review series: adipocyte biology. Sympathetic and sensory innervation of white adipose tissue. J. Lipid Res., 48, 1655-1672.
15. Tchkonia, T., Tchoukalova, Y.D., Giorgadze, N., Pirtskhalava, T., Karagiannides, I., Forse, R.A., Koo, A., Stevenson, M., Chinnappan, D., Cartwright, A., Jensen, M.D., and Kirkland, J.L. (2005) Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am. J. Physiol. Endocrinol. Metab., 288, E267-E277.
16. Tchkonia, T., Giorgadze, N., Pirtskhalava, T., Tchoukalova, Y., Karagiannides, I., Forse, R.A., DePonte, M., Stevenson, M., Guo, W., Han, J., Waloga, G., Lash, T.L., Jensen, M.D., and Kirkland, J.L. (2002) Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol., 282, R1286-R1296.
17. Votruba, S.B. and Jensen, M.D. (2007) Sex differences in abdominal, gluteal, and thigh LPL activity. Am. J. Physiol. Endocrinol. Metab., 292, E1823-E1828.
18. van Harmelen, V., Reynisdottir, S., Eriksson, P., Thorne, A., Hoffstedt, J., Lonnqvist, F., and Arner, P. (1998) Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes, 47, 913-917.
19. Skurk, T., berti-Huber, C., Herder, C., and Hauner, H. (2007) Relationship between adipocyte size and adipokine expression and secretion. J. Clin. Endocrinol. Metab., 92, 1023-1033.
20. Boivin, A., Brochu, G., Marceau, S., Marceau, P., Hould, F.S., and Tchernof, A. (2007) Regional differences in adipose tissue metabolism in obese men. Metabolism, 56, 533-540.
21. Tchernof, A., Belanger, C., Morisset, A.S., Richard, C., Mailloux, J., Laberge, P., and Dupont, P. (2006) Regional differences in adipose tissue metabolism in women: minor effect of obesity and body fat distribution. Diabetes, 55, 1353-1360.
22. Darimont, C., Avanti, O., Blancher, F., Wagniere, S., Mansourian, R., Zbinden, I., Leone-Vautravers, P., Fuerholz, A., Giusti, V., and Mace, K. (2008) Contribution of mesothelial cells in the expression of inflammatory-related factors in omental adipose tissue of obese subjects. Int. J. Obes., 32, 112-120.
23. van Harmelen, V., Rohrig, K., and Hauner, H., (2004) Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. Metabolism, 53, 632-637.
24. Shahparaki, A., Grunder, L., and Sorisky, A. (2002) Comparison of human abdominal subcutaneous versus omental preadipocyte differentiation in primary culture. Metabolism, 51, 1211-1215.
25. Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A.S., and Obin, M.S. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res., 46, 2347-2355.
26. Fain, J.N., Madan, A.K., Hiler, M.L., Cheema, P., and Bahouth, S.W. (2004) Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology, 145, 2273-2282.
27. Zeyda, M., Farmer, D., Todoric, J., Aszmann, O., Speiser, M., Gyori, G., Zlabinger, G.J., and Stulnig, T.M. (2007) Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int. J. Obes., 31, 1420-1428.
28. Lumeng, C.N., Bodzin, J.L., and Saltiel, A.R. (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest, 117, 175-184.
29. Harkins, J.M., Moustaid-Moussa, N., Chung, Y.J., Penner, K.M., Pestka, J.J., North, C.M., and Claycombe, K.J. (2004) Expression of interleukin-6 is greater in preadipocytes than in adipocytes of 3T3-L1 cells and C57BL/6J and ob/ob mice. J. Nutr., 134, 2673-2677.
30. Bjorntorp, P. (1990) "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis, 10, 493-496.
31. Klein, S. (2004) The case of visceral fat: argument for the defense. J. Clin. Invest., 113, 1530-1532.
32. Frayn, K.N. (2000) Visceral fat and insulin resistance-causative or correlative? Br. J. Nutr., 83 (Suppl. 1), S71-S77.
33. Fontana, L., Eagon, J.C., Trujillo, M.E., Scherer, P.E., and Klein, S. (2007) Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes, 56, 1010-1013.
34. Nielsen, S., Guo, Z., Johnson, C.M., Hensrud, D.D., and Jensen, M.D. (2004) Splanchnic lipolysis in human obesity. J. Clin. Invest., 113, 1582-1588.
35. Pond, C.M. (2005) Adipose tissue and the immune system. Prostaglandins Leukot. Essent. Fatty Acids, 73, 17-30.
36. Gabrielsson, B.G., Johansson, J.M., Lonn, M., Jernas, M., Olbers, T., Peltonen, M., Larsson, I., Lonn, L., Sjostrom, L., Carlsson, B., and Carlsson, L.M. (2003) High expression of complement components in omental adipose tissue in obese men. Obes. Res., 11, 699-708.
37. Arner, P. (1995) Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann. Med., 27, 435-438.
38. Bergman, R.N., Kim, S.P., Hsu, I.R., Catalano, K.J., Chiu, J.D., Kabir, M., Richey, J.M., and Ader, M. (2007) Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am. J. Med., 120, S3-S8.
39. Jensen, M.D. (2006) Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity, 14 (Suppl. 1), 20S-24.
40. Leibel, R.L., Edens, N.K., and Fried, S.K. (1989) Physiologic basis for the control of body fat distribution in humans. Annu. Rev. Nutr., 9, 417-443.
41. Lonnqvist, F., Thorne, A., Large, V., and Arner, P. (1997) Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler. Thromb. Vasc. Biol., 17, 1472-1480.
42. Zierath, J.R., Livingston, J.N., Thorne, A., Bolinder, J., Reynisdottir, S., Lonnqvist, F., and Arner, P. (1998) Regional difference in insulin inhibition of nonesterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway. Diabetologia, 41, 1343-1354.
43. Reynisdottir, S., Dauzats, M., Thorne, A., and Langin, D. (1997) Comparison of hormone-sensitive lipase activity in visceral and subcutaneous human adipose tissue. J. Clin. Endocrinol. Metab., 82, 4162-4166.
44. Fried, S.K., Leibel, R.L., Edens, N.K., and Kral, J.G. (1993) Lipolysis in intraabdominal adipose tissues of obese women and men. Obes. Res., 1, 443-448.
45. Rebuffe-Scrive, M., Anderson, B., Olbe, L., and Bjorntorp, P. (1990) Metabolism of adipose tissue in intraabdominal depots in severely obese men and women. Metabolism, 39, 1021-1025.
46. Leibel, R.L., Edens, N.K., and Fried, S.K. (1989) Physiologic basis for the control of body fat distribution in humans. Annu. Rev. Nutr., 9, 417-443.
47. Johnson, J.A., Fried, S.K., Pi-Sunyer, F.X., and Albu, J.B. (2001) Impaired insulin action in subcutaneous adipocytes from women with visceral obesity. Am. J. Physiol. Endocrinol. Metab., 280, E40-E49.
48. Tittelbach, T.J., Blumenthal, J.R., Ryan, A.S., Goldberg, A.P., and Fried, S.K. (2006) Minimal alterations in lipolysis and sensitivity to the antilipolytic effect of insulin in adipocytes of insulin resistant post-menopausal women. Diabetes, 55, A318.
49. Gower, B.A., Munoz, J., Desmond, R., Hilario-Hailey, T., and Jiao, X. (2006) Changes in intra-abdominal fat in early postmenopausal women: effects of hormone use. Obesity, 14, 1046-1055.
50. Dieudonne, M.N., Pecquery, R., Leneveu, M.C., and Giudicelli, Y. (2000) Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor gamma2. Endocrinology, 141, 649-656.
51. Giudicelli, Y., Dieudonne, M.N., Lacasa, D., Pasquier, Y.N., and Pecquery, R. (1993) Modulation by sex hormones of the membranous transducing system regulating fatty acid mobilization in adipose tissue. Prostaglandins Leukot. Essent. Fatty Acids, 48, 91-100.
52. Virtanen, K.A., Lonnroth, P., Parkkola, R., Peltoniemi, P., Asola, M., Viljanen, T., Tolvanen, T., Knuuti, J., Ronnemaa, T., Huupponen, R., and Nuutila, P. (2002) Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J. Clin. Endocrinol. Metab., 87, 3902-3910.
53. Crandall, D.L., Goldstein, B.M., Huggins, F., and Cervoni, P. (1984) Adipocyte blood flow: influence of age, anatomic location, and dietary manipulation. Am. J. Physiol. Regul. Integr. Comp. Physiol., 247, R46-R51.
54. West, D.B., Prinz, W.A., and Greenwood, M.R. (1989) Regional changes in adipose tissue blood flow and metabolism in rats after a meal. Am. J. Physiol. Regul. Integr. Comp. Physiol., 257, R711-R716.
55. Tansey, J.T., Sztalryd, C., Hlavin, E.M., Kimmel, A.R., and Londos, C. (2004) The central role of perilipin a in lipid metabolism and adipocyte lipolysis. IUBMB Life, 56, 379-385.
56. Arner, P. and Langin, D. (2007) The role of neutral lipases in human adipose tissue lipolysis. Curr. Opin. Lipidol., 18, 246-250.
57. Wang, Y., Sullivan, S., Trujillo, M., Lee, M.J., Schneider, S.H., Brolin, R.E., Kang, Y.H., Werber, Y., Greenberg, A.S., and Fried, S.K. (2003) Perilipin expression in human adipose tissues: effects of severe obesity, gender, and depot. Obes. Res., 11, 930-936.
58. Arvidsson, E., Blomqvist, L., and Ryden, M. (2004) Depot-specific differences in perilipin mRNA but not protein expression in obesity. J. Intern. Med., 255, 595-601.
59. Fisher, R.M., Eriksson, P., Hoffstedt, J., Hotamisligil, G.S., Thorne, A., Ryden, M., Hamsten, A., and Arner, P. (2001) Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia, 44, 1268-1273.
60. Hertzel, A.V., Smith, L.A., Berg, A.H., Cline,G.W., Shulman, G.I., Scherer, P.E., and Bernlohr, D.A. (2006) Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice. Am. J. Physiol. Endocrinol. Metab., 290, E814-E823.
61. -/- mice. Am. J. Physiol. Endocrinol. Metab., 288, E187-E193.
62. -/-) after short-term high-fat feeding: functional compensation by the keratinocyte [correction of keritinocyte] fatty acid binding protein. Diabetes, 49, 904-911.
63. Fried, S.K. and Kral, J.G. (1987) Adipose tissue of morbidly obese patients: clinical implications of distribution, morphology, and metabolism. Gastroenterol. Clin. North Am., 16, 207-213.
64. Saleh, J., Christou, N., and Cianflone, K. (1999) Regional specificity of ASP binding in human adipose tissue. Am. J. Physiol. Endocrinol. Metab., 276, E815-E821.
65. Marette, A., Mauriege, P., Marcotte, B., Atgie, C., Bouchard, C., Theriault, G., Bukowiecki, L.J., Marceau, P., Biron, S., Nadeau, A., and Despres, J.P. (1997) Regional variation in adipose tissue insulin action and GLUT4 glucose transporter expression in severely obese premenopausal women. Diabetologia, 40, 590-598.
66. Votruba, S.B., Mattison, R.S., Dumesic, D.A., Koutsari, C., and Jensen, M.D. (2007) Meal fatty acid uptake in visceral fat in women. Diabetes, 56, 2589-2597.
67. Edens, N.K., Fried, S.K., Kral, J.G., Hirsch, J., and Leibel, R.L. (1993) In vitro lipid synthesis in human adipose tissue from three abdominal sites. Am. J. Physiol. Endocrinol. Metab., 265, E374-E379.
68. Bashan, N., Dorfman, K., Tarnovscki, T., Harman-Boehm, I., Liberty, I.F., Bluher, M., Ovadia, S., Maymon-Zilberstein, T., Potashnik, R., Stumvoll, M., Avinoach, E., and Rudich, A. (2007) Mitogenactivated protein kinases, inhibitorykappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. Endocrinology, 148, 2955-2962.
69. Yang, R.Z., Lee, M.J., Hu, H., Pray, J., Wu, H.B., Hansen, B.C., Shuldiner, A.R., Fried, S.K., McLenithan, J.C., and Gong, D.W. (2006) Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am. J. Physiol. Endocrinol. Metab., 290, E1253-E1261.
70. Hotamisligil, G.S. (2006) Inflammation and metabolic disorders. Nature, 444, 860-867.
71. Tilg, H. and Moschen, A.R. (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol., 6, 772-783.
72. Rondinone, C.M. (2006) Adipocytederived hormones, cytokines, and mediators. Endocrine, 29, 81-90.
73. Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. (1993) Adipose expression of tumor necrosis factoralpha: direct role in obesity-linked insulin resistance. Science, 259, 87-91.
74. Senn, J.J., Klover, P.J., Nowak, I.A., and Mooney, R.A. (2002) Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes, 51, 3391-3399.
75. Tuncman, G., Hirosumi, J., Solinas, G., Chang, L., Karin, M., and Hotamisligil, G.S. (2006) Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA, 103, 10741-10746.
76. Kloting, N., Graham, T.E., Berndt, J., Kralisch, S., Kovacs, P., Wason, C.J., Fasshauer, M., Schon, M.R., Stumvoll, M., Bluher, M., and Kahn, B.B. (2007) Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab., 6, 79-87.
77. Yao-Borengasser, A., Varma, V., Bodles, A.M., Rasouli, N., Phanavanh, B., Lee, M.J., Starks, T., Kern, L.M., Spencer, H.J. III, Rashidi, A.A., McGehee, R.E. Jr., Fried, S.K., and Kern, P.A. (2007) Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J. Clin. Endocrinol. Metab., 92, 2590-2597.
78. Sjoholm, K., Palming, J., Olofsson, L.E., Gummesson, A., Svensson, P.A., Lystig, T.C., Jennische, E., Brandberg, J., Torgerson, J.S., Carlsson, B., and Carlsson, L.M. (2005) A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J. Clin. Endocrinol. Metab., 90, 2233-2239.
79. de Souza Batista, C.M., Yang, R.Z., Lee, M.J., Glynn, N.M., Yu, D.Z., Pray, J., Ndubuizu, K., Patil, S., Schwartz, A., Kligman, M., Fried, S.K., Gong, D.W., Shuldiner, A.R., Pollin, T.I., and McLenithan, J.C. (2007) Omentin plasma levels and gene expression are decreased in obesity. Diabetes, 56, 1655-1661.
80. Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., Watanabe, E., Takagi, T., Akiyoshi, M., Ohtsubo, T., Kihara, S., Yamashita, S., Makishima, M., Funahashi, T., Yamanaka, S., Hiramatsu, R., Matsuzawa, Y., and Shimomura, I. (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 307, 426-430.
81. Berndt, J., Kloting, N., Kralisch, S., Kovacs, P., Fasshauer, M., Schon, M.R., Stumvoll, M., and Bluher, M. (2005) Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes, 54, 2911-2916.
82. Varma, V., Yao-Borengasser, A., Rasouli, N., Bodles, A.M., Phanavanh, B., Lee, M.J., Starks, T., Kern, L.M., Spencer, H.J. III, McGehee, R.E. Jr., Fried, S.K., and Kern, P.A. (2007) Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation. J. Clin. Endocrinol. Metab., 92, 666-672.
83. Yang, H., Yang, T., Baur, J.A., Perez, E., Matsui, T., Carmona, J.J., Lamming, D.W., Souza-Pinto, N.C., Bohr, V.A., Rosenzweig, A., de, C.R., Sauve, A.A., and Sinclair, D.A. (2007) Nutrientsensitive mitochondrial NAD{thorn} levels dictate cell survival. Cell, 130, 1095-1107.
84. Tanaka, M., Nozaki, M., Fukuhara, A., Segawa, K., Aoki, N., Matsuda, M., Komuro, R., and Shimomura, I. (2007) Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway. Biochem. Biophys. Res. Commun., 359, 194-201.
85. Yang, R.Z., Lee, M.J., Hu, H., Pollin, T.I., Ryan, A.S., Nicklas, B.J., Snitker, S., Horenstein, R.B., Hull, K., Goldberg, N.H., Goldberg, A.P., Shuldiner, A.R., Fried, S.K., and Gong, D.W. (2006) Acutephase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med., 3, e287.
86. Johnson, B.D., Kip, K.E., Marroquin, O.C., Ridker, P.M., Kelsey, S.F., Shaw, L.J., Pepine, C.J., Sharaf, B., BaireyMerz, C.N., Sopko, G., Olson, M.B., and Reis, S.E. (2004) Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation, 109, 726-732.
87. van der Westhuyzen, D.R., Cai, L., de Beer, M.C., and de Beer, F.C. (2005) Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor BI. J. Biol. Chem., 280, 35890-35895.
88. Cai, L., de Beer, M.C., de Beer, F.C., and van der Westhuyzen, D.R. (2005) Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. J. Biol. Chem., 280, 2954-2961.
89. Marsche, G., Frank, S., Raynes, J.G., Kozarsky, K.F., Sattler, W., and Malle, E. (2007) The lipidation status of acutephase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I. Biochem. J., 402, 117-124.
90. Han, C.Y., Subramanian, S., Chan, C.K., Omer, M., Chiba, T., Wight, T.N., and Chait, A. (2007) Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes, 56, 2260-2273.
91. Memoli, B., Procino, A., Calabro, P., Esposito, P., Grandaliano, G., Pertosa, G., Del Prete, M.A., Andreucci, M., Dilillo, S., Ferulano, G., Cillo, C., Savastano, S., Colao, A., and Guida, B. (2007) Inflammation may modulate interleukin 6 and C-reactive protein gene expression in the adipose tissue: the role of IL-6 cell membrane receptor. Am. J. Physiol. Endocrinol. Metab., 293, E1030-E1035.
92. Gordon, S. (2007) Macrophage heterogeneity and tissue lipids. J. Clin. Invest, 117, 89-93.
93. Weisberg, S.P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R.L., and Ferrante, A.W. Jr. (2006) CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest., 116, 115-124.
94. Harman-Boehm, I., Bluher, M., Redel, H., Sion-Vardy, N., Ovadia, S., Avinoach, E., Shai, I., Kloting, N., Stumvoll, M., Bashan, N., and Rudich, A. (2007) Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J. Clin. Endocrinol. Metab., 92, 2240-2247.
95. Ryden, M., Arvidsson, E., Blomqvist, L., Perbeck, L., Dicker, A., and Arner, P. (2004) Targets for TNF-alpha-induced lipolysis in human adipocytes. Biochem. Biophys. Res. Commun., 318, 168-175.
96. Trujillo, M.E., Lee, M.J., Sullivan, S., Feng, J., Schneider, S.H., Greenberg, A.S., and Fried, S.K. (2006) Tumor necrosis factor alpha and glucocorticoid synergistically increase leptin production in human adipose tissue: role for p38 mitogen-activated protein kinase. J. Clin. Endocrinol. Metab., 91, 1484-1490.
97. Trujillo, M.E., Sullivan, S., Harten, I., Schneider, S.H., Greenberg, A.S., and Fried, S.K. (2004) Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J. Clin. Endocrinol. Metab., 89, 5577-5582.
98. Fain, J.N. and Madan, A.K. (2005) Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue. Int. J. Obes., 29, 1299-1307.
99. Zhang, H.H., Halbleib, M., Ahmad, F., Manganiello, V.C., and Greenberg, A.S. (2002) Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes, 51, 2929-2935.
100. Sartipy, P. and Loskutoff, D.J. (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA, 100, 7265-7270.
101. Wu, H., Ghosh, S., Perrard, X.D., Feng, L., Garcia, G.E., Perrard, J.L., Sweeney, J.F., Peterson, L.E., Chan, L., Smith, C.W., and Ballantyne, C.M. (2007) T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation, 115, 1029-1038.
102. Herder, C., Haastert, B., Muller-Scholze, S., Koenig, W., Thorand, B., Holle, R., Wichmann, H.E., Scherbaum, W.A., Martin, S., and Kolb, H. (2005) Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region ofAugsburg Survey S4 (KORA S4). Diabetes, 54 (Suppl. 2), S11-S17.
103. Wilkison, W.O., Choy, L., and Spiegelman, B.M. (1991) Biosynthetic regulation of monobutyrin, an adipocytesecreted lipid with angiogenic activity. J. Biol. Chem., 266, 16886-16891.
104. Quinkler, M., Bujalska, I.J., Tomlinson, J.W., Smith, D.M., and Stewart, P.M. (2006) Depot-specific prostaglandin synthesis in human adipose tissue: a novel possible mechanism of adipogenesis. Gene, 380, 137-143.
105. Brakenhielm, E., Cao, R., Gao, B., Angelin, B., Cannon, B., Parini, P., and Cao, Y. (2004) Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ. Res., 94, 1579-1588.
106. Voros, G., Maquoi, E., Demeulemeester, D., Clerx, N., Collen, D., and Lijnen, H.R. (2005) Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology, 146, 4545-4554.
107. Bell, L.N., Ward, J.L., gawa-Yamauchi, M., Bovenkerk, J.E., Jones, R., Cacucci, B.M., Gupta, C.E., Sheridan, C., Sheridan, K., Shankar, S.S., Steinberg, H.O., March, K.L., and Considine, R.V. (2006) Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am. J. Physiol. Endocrinol. Metab., 291, E843-E848.
108. Saiki, A., Watanabe, F., Murano, T., Miyashita, Y., and Shirai, K. (2006) Hepatocyte growth factor secreted by cultured adipocytes promotes tube formation of vascular endothelial cells in vitro. Int. J. Obes., 30, 1676-1684.
109. Nakagami, H., Morishita, R., Yamamoto, K., Taniyama, Y., Aoki, M., Matsumoto, K., Nakamura, T., Kaneda, Y., Horiuchi, M., and Ogihara, T. (2001) Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKTin endothelial cells. Hypertension, 37, 581-586.
110. Ramis, J.M., Franssen-van Hal, N.L., Kramer, E., Llado, I., Bouillaud, F., Palou, A., and Keijer, J. (2002) Carboxypeptidase E and thrombospondin-1 are differently expressed in subcutaneous and visceral fat of obese subjects. Cell. Mol. Life Sci., 59, 1960-1971.
111. Vohl, M.C., Sladek, R., Robitaille, J., Gurd, S., Marceau, P., Richard, D., Hudson, T.J., and Tchernof, A. (2004) A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes. Res., 12, 1217-1222.
112. Gesta, S., Bluher, M., Yamamoto, Y., Norris, A.W., Berndt, J., Kralisch, S., Boucher, J., Lewis, C., and Kahn, C.R. (2006) Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc. Natl. Acad. Sci. USA, 103, 6676-6681.
113. Tchkonia, T., Lenburg, M., Thomou, T., Giorgadze, N., Frampton, G., Pirtskhalava, T., Cartwright, A., Cartwright, M., Flanagan, J., Karagiannides, I., Gerry, N., Forse, R.A., Tchoukalova, Y., Jensen, M.D., Pothoulakis, C., and Kirkland, J.L. (2007) Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am. J. Physiol. Endocrinol. Metab., 292, E298-E307.
114. Nayer, A. and Shoelson, S. (2007) Differential distribution of adipositis induced by high-fat diet in abdominal fat depots. Diabetes, 56, A71.
115. Hauner, H., Wabitsch, M., and Pfeiffer, E.F. (1988) Differentiation of adipocyte precursor cells from obese and nonobese adult women and from different adipose tissue sites. Horm. Metab Res. Suppl, 19, 35-39.
116. Tchkonia, T., Giorgadze, N., Pirtskhalava, T., Thomou, T., DePonte, M., Koo, A., Forse, R.A., Chinnappan, D., Martin-Ruiz, C., von, Z.T., and Kirkland, J.L. (2006) Fat depot-specific characteristics are retained in strains derived from single human preadipocytes. Diabetes., 55, 2571-2578.
117. Niesler, C.U., Siddle, K., and Prins, J.B. (1998) Human preadipocytes display a depot-specific susceptibility to apoptosis. Diabetes, 47, 1365-1368.
118. Shi, H., Strader, A., Woods, S.C., and Seeley, R.J. (2007) The effect of fat removal on glucose tolerance is depot specific in male and female mice. Am. J. Physiol. Endocrinol. Metab., 293, E1012-E1020.
119. Tran, T.T., Yamamoto, Y., Gesta, S., and Kahn, C.R. (2007) Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab. 7, 410-420.
120. Russell, C.D., Petersen, R.N., Rao, S.P., Ricci, M.R., Prasad, A., Zhang, Y., Brolin, R.E., and Fried, S.K. (1998) Leptin expression in adipose tissue from obese humans: depot-specific regulation by insulin and dexamethasone. Am. J. Physiol. Endocrinol. Metab., 275, E507-E515.
121. Dusserre, E., Moulin, P., and Vidal, H. (2000) Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim. Biophys. Acta, 1500, 88-96.
122. Fisher, F.M., McTernan, P.G., Valsamakis, G., Chetty, R., Harte, A.L., Anwar, A.J., Starcynski, J., Crocker, J., Barnett, A.H., McTernan, C.L., and Kumar, S. (2002) Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status. Horm. Metab. Res., 34, 650-654.
123. Hube, F., Birgel, M., Lee, Y.M., and Hauner, H. (1999) Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest., 29, 672-678.
124. Alessi, M.C., Bastelica, D., Morange, P., Berthet, B., Leduc, I., Verdier, M., Geel, O., and Juhan-Vague, I. (2000) Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes, 49, 1374-1380.
125. Fried, S.K., Bunkin, D.A., andGreenberg, A.S. (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab., 83, 847-850.
126. Bruun, J.M., Lihn, A.S., Madan, A.K., Pedersen, S.B., Schiott, K.M., Fain, J.N., and Richelsen, B. (2004) Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am. J. Physiol. Endocrinol. Metab., 286, E8-E13.
127. Herder, C., Hauner, H., Kempf, K., Kolb, H., and Skurk, T. (2007) Constitutive and regulated expression and secretion of interferon-gamma-inducible protein 10 (IP-10/CXCL10) in human adipocytes. Int. J. Obes., 31, 403-410.
128. Bruun, J.M., Lihn, A.S., Pedersen, S.B., and Richelsen, B. (2005) Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J. Clin. Endocrinol. Metab., 90, 2282-2289.
129. Tchkonia, T., Lenburg, M., Thomou, T., Giorgadze, N., Frampton, G., Pirtskhalava, T., Cartwright, A., Cartwright, M., Flanagan, J., Karagiannides, I., Gerry, N., Forse, R.A., Tchoukalova, Y., Jensen, M.D., Pothoulakis, C., and Kirkland, J.L. (2006) Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am. J. Physiol. Endocrinol. Metab., 292, 298-307.
130. Fain, J.N., Cheema, P.S., Bahouth, S.W., and Lloyd, H.M. (2003) Resistin release by human adipose tissue explants in primary culture. Biochem. Biophys. Res. Commun., 300, 674-678.
131. Schaffler, A., Neumeier, M., Herfarth, H., Furst, A., Scholmerich, J., and Buchler, C. (2005) Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim. Biophys. Acta, 1732, 96-102.
132. Gabrielsson, B.G., Johansson, J.M., Jennische, E., Jernas, M., Itoh, Y., Peltonen, M., Olbers, T., Lonn, L., Lonroth, H., Sjostrom, L., Carlsson, B., Carlsson, L.M., and Lonn, M. (2002) Depot-specific expression of fibroblast growth factors in human adipose tissue. Obes. Res., 10, 608-616.
133. Lee, M.J., Fried, S.K., Mundt, S.S, Wang, Y., Sullivan, S., Stefanni, A., Daugherty, B.L, andHermanovski-Vosatka, A. (2008) Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue. Obesity, 16, 1178-1185.